The study of the origin and development of cerebellar tumours has been hampered by the complexity and heterogeneity of cerebellar cells that change over the course of development.
Introduction
Brain tumors are the leading type of solid cancer in childhood, and a major source of pediatric morbidity and mortality. In childhood, brain tumors are most commonly found in the posterior fossa, particularly the cerebellum, where medulloblastoma, ependymoma, and pilocytic astrocytoma account for the vast majority of cases. The most common pediatric brain cancer, 'medulloblastoma' is now known to comprise four molecularly distinct diseases (subgroups), with further clinical and molecular heterogeneity within each subgroup [1] [2] [3] [4] [5] . Sonic Hedgehog (Shh), Group 3, and Group 4 medulloblastoma are thought to be tumors of the cerebellum [6] [7] [8] [9] [10] [11] , while Wnt medulloblastoma is thought to arise from a lower rhombic lip derived population in the developing brain stem 12 . While Shh medulloblastoma is thought to arise from relatively undifferentiated progenitor cells of the expanding external granule cell layer (EGL) of the cerebellum, careful examination of fully developed Shh medulloblastomas revealed populations of cells with varying levels of differentiation and capacity for further growth, which mirrored the temporal evolution of the developing granule cell hierarchy 13 . It is currently unclear to what extent the other molecular subgroups of medulloblastoma recapitulate a similar developmental hierarchy. Ependymomas are found throughout the central nervous system, but in the posterior fossa (cerebellum), are thought to be largely limited to two variants: PFA and PFB [14] [15] [16] , and have been suggested to arise from regional radial glial-like cells [17] [18] [19] . Molecular subgroups of medulloblastoma and ependymoma are delineated through transcriptomics, (gene expression) as well as patterns of DNA CpG methylation, both of which have been suggested to reflect the cell of origin for that particular molecular tumor subgroup 20, 21 .
Most pediatric cerebellar tumors are currently treated using non-specific therapies such as surgical resection, radiotherapy, and cytotoxic chemotherapy. Biologically-based targeted therapies are largely unavailable as little is known about the biology of these tumors, and they carry only very few somatically mutated driver genes 17, [22] [23] [24] [25] [26] [27] . The cerebellum is made up of a large variety of cell types, with many undergoing temporally regulated differentiation through defined developmental hierarchies [28] [29] [30] . GABAergic neurons, including Purkinje cells and a variety of interneurons arise from the ventricular zone (VZ), while glutamatergic neurons, including those of the cerebellar nuclei (CN), the inner granule cell layer, and the unipolar brush cells (UBCs) arise from the upper rhombic lip. Cerebellar glial cells, including radial glia, astrocytes, and Bergmann glia also arise from stem cells in the VZ that produces a proliferating progenitor still present in the cerebellar cortex after birth [31] [32] [33] . In the past, transcriptional studies of bulk cerebellar tissue were performed on a complex mixture of intermixed GABAergic neurons, glutamatergic neurons, glia, and non-neuronal cells (such as endothelial cells and microglia). This mixed transcriptome from normal bulk cerebellum precludes a meaningful comparison to the transcriptome or epigenome of cerebellar tumors.
Massive changes during early development, and the relative inaccessibility of the cerebellum inside the skull further complicate the study of the normal developing cerebellum, particularly from human samples. However, the recent development of large-scale single cell transcriptomics permits the development of a 'cellular scaffold' for cerebellar development in which the transcriptomes of distinct hierarchies can be determined at various points in time,
and subsequently compared to the transcriptomes of childhood cerebellar tumors.
Identification of temporally and lineage restricted cell populations in the developing cerebellum that most closely mirror the transcriptome of cerebellar neoplasms could allow for identification of tumor cells of origin, as transcriptional similarity could be construed as good evidence for the lineage of cellular origin. It remains however possible that a more differentiated cell could 'de-differentiate,' or a cell from another lineage hierarchy could 'trans-differentiate' during the process of transformation 33 . Evidence for dedifferentiation or transdifferentiation types of cell fate switching is not common for human brain tumors.
Cerebellar tumors have a low mutational burden, further strengthening their association with their cell of origin. Additional benefits of matching cerebellar tumors to their transcriptional best match from cerebellar development include the discovery of developmental checkpoints that are defective in cerebellar tumors, the development of faithful mouse models of cancer, and direct comparison of tumor and normal cell transcriptomes. Together, such insights into the process of transformation from a normal cerebellar cell to a cerebellar cancer cell could lead to the development of novel targeted therapies.
Identification of transcriptional clusters in the developing murine cerebellum
The developing cerebellum is known to contain a large diversity of neuronal and glial cell progenitors that change over the course of brain development. We isolated the mesial cerebellum progenitors, and to a novel cluster of 'roof plate-like' stem cells. This latter cell cluster has transcriptional similarity to the developing roof plate (Lmx1a, Msx1, Bmp7) 34, 35 . The gliogenic progenitor cluster is observed initially at E12, peaks at E18, and is largely absent by P5
(Supplementary Figure 4) . The roof plate-like stem cells are seen much earlier, in a very restricted period from E10-E12 (Supplementary Figure 4) . This is consistent with PFA, PFB, and C-PA being classified as 'gliomas', and prior publications that suggest that posterior fossa ependymomas arise from the regional radial glia 19 .
Posterior fossa ependymomas and C-PAs are both histologically and clinically distinct from each other. We re-clustered cells belonging to the gliogenic progenitor, early VZ radial glia, and roof plate-stem cells to identify heterogeneity within this developmental cell hierarchy, and identified eight distinct transcriptional clusters within this lineage, with each cluster . These data suggest that transcriptional differences between Group 4β and Group 4γ could be secondary to their arising at different time points from cells in the unipolar brush cell lineage 1 .
We did not attempt to temporally position Group 3 medulloblastomas using bulk transcriptomics, as Group 3 tumors often transcriptionally match more than one cell type cluster in the developing cerebellum. While PFA, PFB, C-PA, and Grp4 MB are all transcriptionally best matched to cell clusters present during fetal development, Shh medulloblastomas are best matched to cells in the granule cell lineage in the early post-natal period at P5 (Figure 4g ,h), consistent with the known peak of proliferation of granule cell progenitors at P5-P7 6 . We conclude that in addition to transcriptional mirroring of specific cell populations in the developing cerebellum, human cerebellar tumor transcriptomes are most similar to specific cell lineages detected at specific time points during development, which in most cases are during fetal life.
Single cell heterogeneity in human cerebellar tumors.
Medulloblastomas are known to exhibit well-characterized intertumoral heterogeneity, as well as geographic, spatial (metastases) and temporal (at recurrence) heterogeneity 1, 23, 25, [36] [37] [38] [39] [40] . Posterior fossa (cerebellar) ependymomas also show marked intertumoral heterogeneity [15] [16] [17] [18] [19] 27 , while the intertumoral heterogeneity amongst cerebellar pilocytic astrocytomas is not well characterized 26 Figure 9) . Two distinct types of UBC have been described in the mammalian cerebellum 41 , and, re-clustering of murine cerebellar cells in the UBC lineage reveals two distinct types of UBC (Supplementary Figure 9) . Group 4 MB is predominantly similar to only one of these subtypes (CR +ve UBCs -Supplementary Figure 9 ). Individual cells from 'cluster 7' simultaneously express both GPC and UBC marker genes, which is not observed in cells committed to a GPC or a UBC fate (Supplemental Figure 11) . Similarly, individual
Group 4 medulloblastoma cells similar to 'cluster 7' also express both GPC and UBC markers. day 0, 5, 7 and 14. The central nervous system was fully dissected, then embedded in 2% Low melting point agarose. One mid saggital slice of 300 um was generated using the Leica vibratome 44 . Under the stereoscope the cerebellum was isolated from the slice, followed by immediate single cell dissociation as described above. 
RT, amplification and sequencing

Alignment of raw reads Through 10x
CellRanger's pipeline 45 , the raw base call (BCL) files were demultiplexed into FASTQ files. The FASTQ files were aligned to the reference mouse genome GRCm38 (mm10) to generate raw gene-barcode count matrices. When clustering of multiple samples, we aggregated the multiple runs together to normalize on sequencing depth, and re-computed the gene-barcode matrices.
QC and normalization Low-quality cells were identified and removed from the datasets. We considered low-quality cells as cells with <200-300 genes expressed and cells with high mitochondrial gene content (4 S.D.s above median). We predicted doublets to be cells with relatively high library sizes (4-5 S.D.s above median), and removed them from the analysis.
Low-abundance genes were also removed from the datasets (genes expressed in less than 3 cells). Normalization methods were adapted from Scran's pipeline 46 . Size factors were computed, and were applied to normalize gene expression across the cells to produce normalized log-expression values.
Clustering analysis and visualization
Highly variable genes were detected using Seurat's pipeline 47, 48 , calculating average expression and dispersion for each gene, diving genes into bins, and computing a z-score for dispersion within each bin. We used a z-score of 0.5 as the cutoff of dispersion, and a bottom cutoff of 0.0125 and a high cutoff of 3.0 for average expression. Linear dimensionality reduction was performed using principal component analysis (PCA), and statistically significant principal components were selected using the elbow and jackstraw methods from Seurat. The clusters of cells were identified by a shared nearest neighbor (SNN) modularity optimization based clustering algorithm from Seurat. We then visualized these clusters using t-SNE, t-distributed stochastic neighbor embedding.
Trajectory analysis
The barcodes of selected clusters were normalized using Monocle's dPFeature to remove lowly expressed genes and perform PCA analysis on the remaining genes, for significant PC selection 49 . Cells are then grouped using 'density peak' clustering algorithm.
Differential gene expression analysis was performed using a generalized linear model (GLM), and the top 1000 genes per cluster were selected. Reverse graph embedding (RGE) was then used to reduce the high-dimensionality data into lower dimensional space and build the trajectory 50 . The structure of the trajectory was plotted into two dimensional space using the DRTree dimensionality reduction algorithm and order the cells in pseudo-time.
Creation of cell-type-specific signatures For each cluster identified, the average expression of each gene was calculated. Diferential gene expression was performed using Seurat's likelihood ratio test (LRT) method, and we filtered out genes expressed in less than 25% of the cells. The top differentially expressed genes were used as markers to build a signature gene expression matrix. Genes involved in cell proliferation and ribosome biogenesis were obtained from Ensembls' biomart 51 , and omitted from the matrix. Human orthologues of mouse genes were identified, and used to create the final matrix.
Deconvolution analysis CIBERSORT was used to perform the deconvolution analysis of the bulk and single-cell RNA-seq tumor data against the mouse clusters
52
. The full transcriptomes of the tumor data was used as the input mixture, and the signature gene input was the mouse cluster expression matrix. Quantile normalization was disabled and 100-500 permutations were ran. To test CIBERSORT on our datasets, we created synthetic bulk mixtures from the mouse clusters, and we selected known amount of reads from various clusters. CIBERSORT roughly yielded the expected abundances. To validate our mouse cluster signatures, we obtained FPKM data of brain cell types from published datasets, and deconvoluted them against our mouse signatures.
Bulk RNA-seq human tumor samples 60 SHH, 40 G3, and 45 G4 human medulloblastoma bulk RNA-seq samples were obtained from MAGIC, Medulloblastoma Advanced Genomics
International Consortium. The raw data was aligned to the reference human genome GRChg38 using STAR to generate raw counts 53 . FPKMs were then obtained from DESeq2 
